Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients

Recruiting Observational Study
Systemic Sclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Hôpital Européen Marseille · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Today, the study of gut microbiota has taken a prominent place in several fields of medical research. Numerous experimental data in humans and animals suggest that an imbalance in the composition of the microbiota could contribute to the pathophysiology of systemic autoimmune diseases such as Systemic Sclerosis (SCS). A future exploration of the microbiota, a source of diagnostic and/or prognostic…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For ScS patients: 1. Patients with ScS according to ACR criteria. 2. Patients over 18 years old. 3. Patients who have signed the consent to participate in this study. For control subjects: 1. Persons without diagnosis of ScS or any other chronic disease. 2. Persons over 18 ye…
Contacts

Eya TOUMI, PhD student

04 13 42 81 50

e.toumi@alphabio.fr

CONTACT